This topic contains a solution. Click here to go to the answer

Author Question: ________ refers to a technology that is limited in size, decentralized, and responsive to human ... (Read 56 times)

bb

  • Hero Member
  • *****
  • Posts: 544
________ refers to a technology that is limited in size, decentralized, and responsive to human values and needs.
 
  a. Indigenous technology
  b. Appropriate technology
  c. Capital-intensive technology
  d. Autonomous technology

Question 2

Schools following the back to basics approach to education are most likely to ________.
 
  a. reduce the amount of face-to-face interactions between students and teachers
  b. let students decide if they want to take up academically demanding courses
  c. reduce the number of elective courses and have more required courses
  d. eliminate standardized examinations



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Swizqar

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

Answer: b

Answer to Question 2

Answer: c




bb

  • Member
  • Posts: 544
Reply 2 on: Jul 2, 2018
Great answer, keep it coming :)


anyusername12131

  • Member
  • Posts: 327
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library